Focusing on omni-channel marketing, 2022 Boyun will invite you to "take the pulse" of The transformation of China's pharmaceutical market

While policies such as centralized procurement, dynamic adjustment of medical insurance catalogues, and medical insurance access negotiations tend to be normalized, people's health needs are also increasing, and the opportunities and challenges facing the pharmaceutical industry may be unprecedented new situations

The industry's sages gathered together, and the highlights continued

Since its inception in 2019, the guests and wonderful content shared by each participant have always been a major attraction

In terms of content, this year's Boyun will focus on hot topics such as "China's Pharmaceutical Innovation and Global Development", "Digital View of China's Pharmaceutical Market", "Changing Pharmaceutical Industry", "Evidence-based and Precise Market Strategy in hospital Market", "Successful Factors in the Commercialization of China's Innovative Drugs", "Marketing Innovation of Out-of-Hospital Channels", "County Market under Policy Dividends", "Circulation of China's Pharmaceutical Market Channels", "The Game of Medical Insurance and Medical Care", "Opportunities and Challenges in the Era of Omni-channel Marketing in the Pharmaceutical Market", etc.

Focus on China's pharmaceutical market, omni-channel marketing is the trend

In recent years, our country has vigorously supported the development of primary medical care, and at the same time, the new reform policies promoted by medical insurance represented by volume procurement, DRGs, and national talks have been frequently introduced, facing the intertwining changes of policies and markets, the traditional marketing model has been somewhat inadequate, and the omni-channel marketing model characterized by operational research core market, sinking broad and grass-roots markets, rich online and new retail channels has been more and more valued

In the face of the changes in the pharmaceutical market pattern and the trend of omni-channel marketing upgrading, this year's Boyun will analyze and predict the omni-channel pattern of China's pharmaceutical market, take the data as the yardstick, deeply analyze the overall development of the pharmaceutical industry, market pattern, marketing innovation, focus on China's core drug market, broad market, DTP and other new marketing scenarios, and pay attention to the success of innovative drugs and the countermeasures of generic drugs

Grandly released, the blue book of the development pattern of the pharmaceutical industry

At the same time, the blue book of "Omni-channel Development Pattern of China's Pharmaceutical Market" will also be released at the scene of this year's Boyun Conference, which will show the pattern of the entire Chinese pharmaceutical market through quantitative data industry reports, analyze and look forward to the current development trend of China's pharmaceutical market, and provide data support and strategic empowerment

More highlights and highlights, all in September 7th "2022 BoYun Conference - Number Theory China Pharmaceutical Omni-channel Marketing" conference, we sincerely invite you to attend!

Scan the code to register now